OpenAlex
PricingAboutJobs
Log inGet started
Work

Developing a molecular imaging agent for Met using onartuzumab (MetMAb).

HTML

Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2013.31.15_suppl.11083
Authors: Cara Elizabeth Wright, Elaine Jagoda, Fabiola Cecchi, Veerendra Bhadrasetty, Stephanie Histed, Mark Williams, Gabriela Kramer-Marek, Esther Mena, Lauren Rosenblum, Lixin Lang, Lawrence Szajek, Chang Paik, Peter L. Choyke, Jan Marik, Jeffrey Tinianow, Mark Merchant, Donald P. Bottaro
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, National Institute of Biomedical Imaging and Bioengineering, Genentech
Language: English

Topic: Radiopharmaceutical Chemistry and Applications
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2602336226
Cites:
Cited by: 1
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms